Long-term Egg-Protein Hydrolysate Improves Vascular Health
Study Overview: A recent clinical trial examined the effects of egg-protein hydrolysate (Newtricious NWT-03) on older adults with overweight or obesity. The study aimed to understand its long-term impact on blood vessel function and heart health.
Key Details:
- Participants: 44 older adults (ages 60-75) with overweight or obesity.
- Duration: 36 weeks.
- Method: Participants were given either 5.7 g of egg-protein hydrolysate or a placebo.
Results:
- Endothelial Function: There was a small but notable improvement in blood vessel function after taking the egg-protein supplement.
- Cold Pressor Test: Significant improvement in carotid artery response was observed.
- Other Measurements: No significant changes were found in arterial stiffness, retinal health, or other heart health markers.
Conclusion:
Taking 5.7 g of egg-protein hydrolysate for 36 weeks can enhance blood vessel function in older adults at risk for heart disease. However, other health markers did not show significant changes.
Clinical Trial Registration:
This study is registered at ClinicalTrials.gov under the identifier NCT04831203.
Enhancing Clinical Practice with Technology
Clinical trials are vital for developing effective treatments. To integrate these findings into everyday healthcare, we offer DocSym, an AI-driven platform that consolidates clinical knowledge for healthcare providers.
Practical Solutions:
- Streamlined Operations: Our mobile apps assist with scheduling, treatment monitoring, and telemedicine.
- Improved Patient Care: AI enhances workflows, reduces paperwork, and boosts patient outcomes.
Discover how we can support your practice at aidevmd.com.
